VT3 PRESENTATIONS

  1. Home
  2. VT3 PRESENTATIONS
TOPIC

Six observations from an infection prevention practice exclusively serving long-term care 

SPEAKERS

Dr. Chris Morgan, Medical Director of AMS Onsite
Heather Hutson, Chief Infection Control Officer, AMS Onsite
Ellsworth Harris, CEO, AMS Onsite

SUMMARY

The AMS OnSite clinical practice includes 12 certified Infection Preventionists in multiple states, exclusively serving the long-term care and skilled nursing  communities. In the last five months, AMS OnSite has run 35,000 multi-panel respiratory and COVID-19 tests, as well as gained critical insights into infection control during a pandemic. This presentation explores observations, challenges and lessons learned during this time, and offers insights into how facilities can improve their infection control and prevention practices, including through real-time analytics. And with the flu season fast approaching, the presentation also offers a physician’s perspective on co-infections with COVID-19, as well as multi-drug resistant organisms in long-term care facilities and the importance of antimicrobial stewardship.

OBJECTIVES

Lessons learned in long-term care during the pandemic
Over the last four months, AMS OnSite, a clinical practice with certified Infection Preventionists exclusively serving the long-term care and skilled nursing communities, has facilitated more than 54,000 multi-panel respiratory and COVID-19 tests, as well as gained critical insights into infection control during a pandemic. This presentation explores observations, challenges and lessons learned during this time, and offers course attendees insight into how facilities can improve their infection control and prevention practices.

COVID-19 co-infections
With the flu season fast approaching, the presentation also offers a physician’s perspective on co-infections with COVID-19, particularly influenza and other respiratory ailments, sharing with insight with attendees that include best practices to reduce and control co-infections.

The rise of MDROs
Over-prescribing and improperly prescribing antibiotics have led to multi-drug resistant organisms (MDROs), which cost healthcare organizations billions of dollars each year. A physician explores how attendees can control MDROs in their organizations, starting with aggressive testing of all pathogens, including COVID-19. A good antibiogram program helps control the risks of MDRO. 

Menu